Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

Biotechnology • Healthcare • Chicago, IL, United States • CDIOW (NCM)

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

855 226 9991 311 West Superior Street, Chicago, IL 60654, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory - Yahoo Finance
Yahoo Finance • Jun 9
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - Business Wire
Business Wire • May 8
Cardio Diagnostics (NASDAQ: CDIO) to host Wisdom Wednesdays with YMCA starting Nov 2025 - Stock Titan
Stock Titan • Oct 28
Cardio Diagnostics enacts 1-for-30 reverse stock split - Investing.com
Investing.com • May 8
Cardio Diagnostics Regains Nasdaq Compliance After Reverse Stock Split - Nasdaq
Nasdaq • May 29

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Cardio Diagnostics Holdings, Inc. had layoffs?
No layoff events have been recorded for Cardio Diagnostics Holdings, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Cardio Diagnostics Holdings, Inc. have?
Cardio Diagnostics Holdings, Inc. has approximately 13 employees.
What industry is Cardio Diagnostics Holdings, Inc. in?
Cardio Diagnostics Holdings, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Cardio Diagnostics Holdings, Inc. a publicly traded company?
Yes, Cardio Diagnostics Holdings, Inc. is publicly traded under the ticker symbol CDIOW on the NCM.
Where is Cardio Diagnostics Holdings, Inc. headquartered?
Cardio Diagnostics Holdings, Inc. is headquartered in Chicago, IL, United States at 311 West Superior Street, Chicago, IL 60654, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.